Trials / Withdrawn
WithdrawnNCT03313414
HCV Post-Exposure Prophylaxis for Health Care Workers
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore needles.
Detailed description
The goal of this study is to assess the safety and tolerability of the use of sofosbuvir-velpatasvir in the setting of post-exposure prophylaxis among Health Care Workers exposed to HCV from needlestick injury with hollow-bore needles
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sofosbuvir/Velpatasvir Treatment for 14 days | 14 day therapy with Sofosbuvir/Velpatasvir |
Timeline
- Start date
- 2019-08-13
- Primary completion
- 2020-01-01
- Completion
- 2020-01-16
- First posted
- 2017-10-18
- Last updated
- 2020-01-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03313414. Inclusion in this directory is not an endorsement.